Description
Ocrevus (Ocrelizumab) 300mg/10ml Online
Ocrevus (Ocrelizumab) is a monoclonal antibody that affects the actions of the body’s immune system. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect healthy cells from damage. Ocrevus is used to treat primary progressive multiple sclerosis and relapsing forms of multiple sclerosis in adults (including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease).
Ocrelizumab injection may cause serious reactions during an infusion and up to a day after receiving the infusion. You may be given other medications to treat or help prevent reactions to ocrelizumab. A doctor or nurse will watch you closely while receiving the infusion and for at least 1 hour afterward to provide treatment in case of certain side effects to the medication. Your doctor may temporarily or permanently stop your treatment or decrease the dose if you experience certain side effects. Tell your doctor or nurse if you experience any of the following during or within 24 hours after your infusion: rash; itching; hives; redness at the injection site; difficulty breathing or swallowing; cough; wheezing; rash; feeling faint; throat irritation; mouth or throat pain; shortness of breath; swelling of the face, eyes, mouth, throat, tongue, or lips; flushing; fever; fatigue; tiredness; headache; dizziness; nausea; or a racing heartbeat. Call your doctor immediately or get immediate emergency medical attention if you experience any of these symptoms after you leave your doctor’s office or medical facility.
